Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
TD Bank was fined more than $3 billion by regulators in October in what’s arguably the biggest banking scandal of the year.
Europe’s bank M&A scene has been noticeably stagnant for a while, but that could all be about to change next year.
The Fed’s September rate cut turbo-charged the stock market, but can the market keep up its bull run for 2025?